Changes in ARSB gene expression involving coding and non-coding regions were identified in patients with moderate COPD who were refractory to oxygen therapy in the Long-term Oxygen Treatment Trial (LOTT). The gene discussed is ARSB; the disease is chronic obstructive pulmonary disease.